Xilio Therapeutics GAAP EPS of -$0.16 misses by $0.06
Source: SeekingAlpha
2025-08-14 08:09:49 ET
More on Xilio Therapeutics
- Xilio Therapeutics announces pricing of $50 million public offering
- Xilio Therapeutics announces public offering; shares down
- Seeking Alpha’s Quant Rating on Xilio Therapeutics
- Historical earnings data for Xilio Therapeutics
- Financial information for Xilio Therapeutics
Read the full article on Seeking Alpha
For further details see:
Xilio Therapeutics GAAP EPS of -$0.16 misses by $0.06
Xilio Therapeutics Inc.
NASDAQ: XLO
XLO Trading
-2.15% G/L:
$0.5187 Last:
158,741 Volume:
$0.5113 Open:
XLO Latest News
March 02, 2026 08:00:00 am
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
XLO Stock Data
$36,573,414
29,954,402
2.14%
13
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
